BRAF and colorectal cancer: Prahallad et al. investigated this astounding difference using shRNA mediated knockdown to screen for the involvement of 518 human kinases and 17 additional kinase-related genes and found that knockdown of EGFR sensitized BRAF mutant colorectal cancer cells to BRAF inhibition.